{"id":4846,"date":"2025-10-31T08:17:16","date_gmt":"2025-10-31T07:17:16","guid":{"rendered":"https:\/\/afpca.fr\/site\/?page_id=4846"},"modified":"2025-10-31T08:52:17","modified_gmt":"2025-10-31T07:52:17","slug":"presentation-ag-2012","status":"publish","type":"page","link":"https:\/\/afpca.fr\/site\/espace-adherent-afpca\/archives\/presentation-ag-2012\/","title":{"rendered":"pr\u00e9sentation AG 2012"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"4846\" class=\"elementor elementor-4846\">\n\t\t\t\t<div class=\"elementor-element elementor-element-bde8759 e-flex e-con-boxed e-con e-parent\" data-id=\"bde8759\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f928a0b elementor-widget elementor-widget-heading\" data-id=\"f928a0b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Pr\u00e9sentation Pr JC PIETTE (CHU Piti\u00e9-Salp\u00e9tri\u00e8re)\u00a0:\u00a0Diversit\u00e9 des associations possibles et PCA<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-ed854c9 e-flex e-con-boxed e-con e-parent\" data-id=\"ed854c9\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-95c11ee elementor-widget elementor-widget-text-editor\" data-id=\"95c11ee\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/10\/PCA_Maladies_associees_2012.pdf\">&#8211;&gt; voir la pr\u00e9sentation sur la diversit\u00e9 des associations possibles avec la PCA<\/a><\/p><ul><li><u><strong>Polychondrite : Affections associ\u00e9es<\/strong><\/u><ul><li>Syndrome de Gougerot-Sj\u00f6gren<\/li><li>Lupus syst\u00e9mique<\/li><li>Arthrite rhumato\u00efde<\/li><li>Pelvispondylite<\/li><li>Fiessinger-Leroy-Reiter<\/li><li>Dysthyro\u00efdies<\/li><li>Diab\u00e8te<\/li><li>Cirrhose biliaire primitive<\/li><li>Colites inflammatoires<\/li><li>Maladie de Beh\u00e7et<\/li><li>Maladie de Takayasu ?<\/li><li>MPA<\/li><li>Maladie de Wegener<\/li><li>Dys\u00e9rythropo\u00ef\u00e8se acquise<\/li><li>H\u00e9mopathies my\u00e9lo\u00efdesmalignes<\/li><\/ul><\/li><\/ul><ul><li><u><strong>Syndrome de Gougerot-Sj\u00f6gren<\/strong><\/u><strong>\u00a0 \u00a0(diagnostic = 4 crit\u00e8res dont 5. et 6.)<\/strong><ol><li>Les crit\u00e8res europ\u00e9ens r\u00e9vis\u00e9s<\/li><li>Sensation de bouche s\u00e8che<\/li><li>Sensation d\u2019\u0153il sec<\/li><li>Test Shirmer \u2264 \u00e0 5 mm en 5 mn ou Van Bijsterfeld \u2265 4<\/li><li>Scintigraphie salivaire ou flux salivaire \u2264 1.5 ml \/ 15 mn<\/li><li>Focus score \u2265 \u00e0 1 : grade 3 ou 4 de Chisholm<\/li><li>Ac anti-SS A ou anti-SS B<\/li><\/ol><\/li><\/ul><p style=\"padding-left: 80px;\">Syndrome de GOUGEROT-SJ\u00d6GREN associ\u00e9 est fr\u00e9quent, g\u00eanant, pas grave.<\/p><ul><li><u><strong>Maladie de <\/strong><\/u><u><strong>Behcet<\/strong><\/u><\/li><\/ul><p style=\"padding-left: 40px;\">La maladie de Beh\u00e7et est une vascularite syst\u00e9mique chronique caract\u00e9ris\u00e9e par des inflammations des vaisseaux sanguins, avec des sympt\u00f4mes tels que ulc\u00e8res buccaux et g\u00e9nitaux, atteintes oculaires, cutan\u00e9es, articulaires, neurologiques ou cardiovasculaires<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-26a0183 e-flex e-con-boxed e-con e-parent\" data-id=\"26a0183\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-80ef96a elementor-widget elementor-widget-image\" data-id=\"80ef96a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"389\" height=\"251\" src=\"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/10\/Picture.png\" class=\"attachment-large size-large wp-image-4863\" alt=\"\" srcset=\"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/10\/Picture.png 389w, https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/10\/Picture-300x194.png 300w\" sizes=\"(max-width: 389px) 100vw, 389px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-8e2dd31 elementor-widget elementor-widget-text-editor\" data-id=\"8e2dd31\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<ul><li><u><strong>Maladie de Takayasu<\/strong><\/u><\/li><\/ul><p style=\"padding-left: 40px;\">La maladie de Takayasu est une vascularite inflammatoire\u00a0affectant principalement l\u2019aorte et ses branches et se manifestant par des troubles isch\u00e9miques, st\u00e9noses ou dilatations art\u00e9rielles<\/p><ul><li><u><strong>Dys\u00e9rythropo\u00ef\u00e8se acquise = My\u00e9lodysplasie \u2248 An\u00e9mie r\u00e9fractaire<\/strong><\/u><\/li><li>Surtout sexe masculin<\/li><li>Surtout apr\u00e8s 60 ans&#8221;<\/li><li>Pendant plusieurs ann\u00e9es\u00a0: macrocytose isol\u00e9e<\/li><li>Puis an\u00e9mie peu r\u00e9g\u00e9n\u00e9rative \u00b1 baisse des globules blancs et\/ou des plaquettes<\/li><li>Transformation\u00a0: rare<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-b2bf0ce e-flex e-con-boxed e-con e-parent\" data-id=\"b2bf0ce\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-81cd34a elementor-widget elementor-widget-heading\" data-id=\"81cd34a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Pr\u00e9sentation du Dr Didier Bouccara  Service ORL du Pr Olivier Sterkers - H\u00f4pital Beaujon  \nLes probl\u00e8mes audio-vestibulaires li\u00e9s \u00e0 la PC<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-3f43d70 e-flex e-con-boxed e-con e-parent\" data-id=\"3f43d70\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d5225c4 elementor-widget elementor-widget-text-editor\" data-id=\"d5225c4\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><a href=\"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/10\/Troubles_-audition.pdf\">\u00a0&#8211;&gt; voir la pr\u00e9sentation sur les troubles de l&#8217;audition<\/a><\/p><ul><li><strong><u>Sympt\u00f4mes<\/u><u> ORL au cours de la PCA<\/u><\/strong><ul><li>Chondrite auriculaire : 90 % des patients au cours de l\u2019\u00e9volution<\/li><li>Atteinte laryngo-trach\u00e9o-bronchique : inflammation avec \u0153d\u00e8me puis st\u00e9nose possible<\/li><li>Chondrite nasale, puis ensellure nasale<\/li><li>Atteinte auditive brutale ou progressive, souvent bilat\u00e9rale,<\/li><li>Vertiges<\/li><li>Par atteinte de la trompe d\u2019Eustache ou de l\u2019oreille interne<strong><u><br \/><\/u><\/strong><\/li><\/ul><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Pr\u00e9sentation Pr JC PIETTE (CHU Piti\u00e9-Salp\u00e9tri\u00e8re)\u00a0:\u00a0Diversit\u00e9 des associations possibles et PCA &#8211;&gt; voir la pr\u00e9sentation sur la diversit\u00e9 des associations possibles avec la PCA Polychondrite : Affections associ\u00e9es Syndrome de Gougerot-Sj\u00f6gren Lupus syst\u00e9mique Arthrite rhumato\u00efde Pelvispondylite Fiessinger-Leroy-Reiter Dysthyro\u00efdies Diab\u00e8te Cirrhose biliaire primitive Colites inflammatoires Maladie de Beh\u00e7et Maladie de Takayasu ? MPA Maladie de Wegener [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"parent":4783,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-4846","page","type-page","status-publish","hentry","post"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>pr\u00e9sentation AG 2012 - Association Francophone Contre La Polychondrite Chronique Atrophiante<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/afpca.fr\/site\/espace-adherent-afpca\/archives\/presentation-ag-2012\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"pr\u00e9sentation AG 2012 - Association Francophone Contre La Polychondrite Chronique Atrophiante\" \/>\n<meta property=\"og:description\" content=\"Pr\u00e9sentation Pr JC PIETTE (CHU Piti\u00e9-Salp\u00e9tri\u00e8re)\u00a0:\u00a0Diversit\u00e9 des associations possibles et PCA &#8211;&gt; voir la pr\u00e9sentation sur la diversit\u00e9 des associations possibles avec la PCA Polychondrite : Affections associ\u00e9es Syndrome de Gougerot-Sj\u00f6gren Lupus syst\u00e9mique Arthrite rhumato\u00efde Pelvispondylite Fiessinger-Leroy-Reiter Dysthyro\u00efdies Diab\u00e8te Cirrhose biliaire primitive Colites inflammatoires Maladie de Beh\u00e7et Maladie de Takayasu ? MPA Maladie de Wegener [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/afpca.fr\/site\/espace-adherent-afpca\/archives\/presentation-ag-2012\/\" \/>\n<meta property=\"og:site_name\" content=\"Association Francophone Contre La Polychondrite Chronique Atrophiante\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/groups\/42710644010\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-31T07:52:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/10\/Picture.png\" \/>\n\t<meta property=\"og:image:width\" content=\"389\" \/>\n\t<meta property=\"og:image:height\" content=\"251\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/espace-adherent-afpca\\\/archives\\\/presentation-ag-2012\\\/\",\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/espace-adherent-afpca\\\/archives\\\/presentation-ag-2012\\\/\",\"name\":\"pr\u00e9sentation AG 2012 - Association Francophone Contre La Polychondrite Chronique Atrophiante\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/espace-adherent-afpca\\\/archives\\\/presentation-ag-2012\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/espace-adherent-afpca\\\/archives\\\/presentation-ag-2012\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Picture.png\",\"datePublished\":\"2025-10-31T07:17:16+00:00\",\"dateModified\":\"2025-10-31T07:52:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/espace-adherent-afpca\\\/archives\\\/presentation-ag-2012\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/afpca.fr\\\/site\\\/espace-adherent-afpca\\\/archives\\\/presentation-ag-2012\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/espace-adherent-afpca\\\/archives\\\/presentation-ag-2012\\\/#primaryimage\",\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Picture.png\",\"contentUrl\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/Picture.png\",\"width\":389,\"height\":251},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/espace-adherent-afpca\\\/archives\\\/presentation-ag-2012\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/afpca.fr\\\/site\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Espace adh\u00e9rent AFPCA\",\"item\":\"https:\\\/\\\/afpca.fr\\\/site\\\/espace-adherent-afpca\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Archives\",\"item\":\"https:\\\/\\\/afpca.fr\\\/site\\\/espace-adherent-afpca\\\/archives\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"pr\u00e9sentation AG 2012\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#website\",\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/\",\"name\":\"Association Francophone Contre La Polychondrite Chronique Atrophiante\",\"description\":\"Association Francophone Contre La Polychondrite Chronique Atrophiante\",\"publisher\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/afpca.fr\\\/site\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#organization\",\"name\":\"Association Francophone Contre La Polychondrite Chronique Atrophiante\",\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/LOGO_afpca.png\",\"contentUrl\":\"https:\\\/\\\/afpca.fr\\\/site\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/LOGO_afpca.png\",\"width\":184,\"height\":184,\"caption\":\"Association Francophone Contre La Polychondrite Chronique Atrophiante\"},\"image\":{\"@id\":\"https:\\\/\\\/afpca.fr\\\/site\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/groups\\\/42710644010\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"pr\u00e9sentation AG 2012 - Association Francophone Contre La Polychondrite Chronique Atrophiante","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/afpca.fr\/site\/espace-adherent-afpca\/archives\/presentation-ag-2012\/","og_locale":"fr_FR","og_type":"article","og_title":"pr\u00e9sentation AG 2012 - Association Francophone Contre La Polychondrite Chronique Atrophiante","og_description":"Pr\u00e9sentation Pr JC PIETTE (CHU Piti\u00e9-Salp\u00e9tri\u00e8re)\u00a0:\u00a0Diversit\u00e9 des associations possibles et PCA &#8211;&gt; voir la pr\u00e9sentation sur la diversit\u00e9 des associations possibles avec la PCA Polychondrite : Affections associ\u00e9es Syndrome de Gougerot-Sj\u00f6gren Lupus syst\u00e9mique Arthrite rhumato\u00efde Pelvispondylite Fiessinger-Leroy-Reiter Dysthyro\u00efdies Diab\u00e8te Cirrhose biliaire primitive Colites inflammatoires Maladie de Beh\u00e7et Maladie de Takayasu ? MPA Maladie de Wegener [&hellip;]","og_url":"https:\/\/afpca.fr\/site\/espace-adherent-afpca\/archives\/presentation-ag-2012\/","og_site_name":"Association Francophone Contre La Polychondrite Chronique Atrophiante","article_publisher":"https:\/\/www.facebook.com\/groups\/42710644010","article_modified_time":"2025-10-31T07:52:17+00:00","og_image":[{"width":389,"height":251,"url":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/10\/Picture.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/afpca.fr\/site\/espace-adherent-afpca\/archives\/presentation-ag-2012\/","url":"https:\/\/afpca.fr\/site\/espace-adherent-afpca\/archives\/presentation-ag-2012\/","name":"pr\u00e9sentation AG 2012 - Association Francophone Contre La Polychondrite Chronique Atrophiante","isPartOf":{"@id":"https:\/\/afpca.fr\/site\/#website"},"primaryImageOfPage":{"@id":"https:\/\/afpca.fr\/site\/espace-adherent-afpca\/archives\/presentation-ag-2012\/#primaryimage"},"image":{"@id":"https:\/\/afpca.fr\/site\/espace-adherent-afpca\/archives\/presentation-ag-2012\/#primaryimage"},"thumbnailUrl":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/10\/Picture.png","datePublished":"2025-10-31T07:17:16+00:00","dateModified":"2025-10-31T07:52:17+00:00","breadcrumb":{"@id":"https:\/\/afpca.fr\/site\/espace-adherent-afpca\/archives\/presentation-ag-2012\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/afpca.fr\/site\/espace-adherent-afpca\/archives\/presentation-ag-2012\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/afpca.fr\/site\/espace-adherent-afpca\/archives\/presentation-ag-2012\/#primaryimage","url":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/10\/Picture.png","contentUrl":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2025\/10\/Picture.png","width":389,"height":251},{"@type":"BreadcrumbList","@id":"https:\/\/afpca.fr\/site\/espace-adherent-afpca\/archives\/presentation-ag-2012\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/afpca.fr\/site\/"},{"@type":"ListItem","position":2,"name":"Espace adh\u00e9rent AFPCA","item":"https:\/\/afpca.fr\/site\/espace-adherent-afpca\/"},{"@type":"ListItem","position":3,"name":"Archives","item":"https:\/\/afpca.fr\/site\/espace-adherent-afpca\/archives\/"},{"@type":"ListItem","position":4,"name":"pr\u00e9sentation AG 2012"}]},{"@type":"WebSite","@id":"https:\/\/afpca.fr\/site\/#website","url":"https:\/\/afpca.fr\/site\/","name":"Association Francophone Contre La Polychondrite Chronique Atrophiante","description":"Association Francophone Contre La Polychondrite Chronique Atrophiante","publisher":{"@id":"https:\/\/afpca.fr\/site\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/afpca.fr\/site\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/afpca.fr\/site\/#organization","name":"Association Francophone Contre La Polychondrite Chronique Atrophiante","url":"https:\/\/afpca.fr\/site\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/afpca.fr\/site\/#\/schema\/logo\/image\/","url":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2023\/05\/LOGO_afpca.png","contentUrl":"https:\/\/afpca.fr\/site\/wp-content\/uploads\/2023\/05\/LOGO_afpca.png","width":184,"height":184,"caption":"Association Francophone Contre La Polychondrite Chronique Atrophiante"},"image":{"@id":"https:\/\/afpca.fr\/site\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/groups\/42710644010"]}]}},"_links":{"self":[{"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/pages\/4846","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/comments?post=4846"}],"version-history":[{"count":21,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/pages\/4846\/revisions"}],"predecessor-version":[{"id":4869,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/pages\/4846\/revisions\/4869"}],"up":[{"embeddable":true,"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/pages\/4783"}],"wp:attachment":[{"href":"https:\/\/afpca.fr\/site\/wp-json\/wp\/v2\/media?parent=4846"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}